• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
TechAmazon

Dr. Oz Says Amazon Should Get Into the Prescription Drug Business

Barb Darrow
By
Barb Darrow
Barb Darrow
Down Arrow Button Icon
Barb Darrow
By
Barb Darrow
Barb Darrow
Down Arrow Button Icon
October 20, 2017, 8:34 AM ET

Dr. Mehmet Oz, a heart surgeon and TV show host, likes the idea of Amazon getting into the prescription drug distribution business.

Amazon (AMZN) already has a massive delivery logistics infrastructure in place, and its entry into this market could bring needed transparency into drug pricing, Oz told The Street in an interview on Thursday.

“Amazon has gone into a lot of sectors that aren’t as efficient as they could be and forced efficiency,” Oz told the financial news site. “The big part is there needs to be transparency—everyone needs to know what the drugs cost. I’m a heart surgeon and when I prescribe something I have no idea what the drug prices would be.”

Related: Dr. Oz and GMOs—When Controversy Meets Controversy

Physicians, according to Oz, would like an app that lets them quickly call up a patient’s insurance carrier, look at drug options, and find a lower cost choice when needed. “Here’s a pill you take once a day for $100 and another you could take twice a day for $5,” Oz explained.

Related: Amazon Gets Serious About Selling Drugs

Earlier this month, CNBC reported that the retail and tech giant is weighing a plan to enter this business, which is estimated to be worth nearly $560 billion a year. Amazon did not comment on that report.

Get Data Sheet, Coins2Day’s technology newsletter

Amazon, founded by Jeff Bezos as an online bookseller in 1994, has indeed branched out: It now sells pretty much anything from toys to streaming video to appliances to IT services via its Amazon Web Services arm.

About the Author
Barb Darrow
By Barb Darrow
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.